Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)

Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis

The purpose of this study is to assess whether timely feedback to providers on patient experiences with delayed chemotherapy induced nausea and vomiting (CINV) lead to differences in patient outcomes for subsequent cycles.

Inclusion Criteria:

• Highly or moderately emetogenic chemotherapy planned for at least 2 cycles

Exclusion Criteria:

• Concurrent other anti-cancer therapy (e.g. radiation, hormone, etc.); vomiting during the 24 hours prior to first chemotherapy cycle; having a disease/condition or taking medication that may cause emesis